HeavenlyRx, a CBD maker based in Toronto, on Tuesday announced the acquisition of a privately held CBD manufacturer in the United States.
The purchase of Paradise Valley-based PureKana expands HeavenlyRx’s reach into Arizona and continues a recent string of acquisitions by the Sol Global Investments subsidiary.
HeavenlyRx most recently added to its portfolio in November with the planned takeover of Therapix Biosciences, an Israeli company that develops cannabinoid pharmaceuticals.
PureKana will continue to manufacture CBD gummies, topicals and oils under the PureKana brand.
